Synchron Company
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Investors
Funding Status:
Late Stage Venture
Headquarters:
Brooklyn, New York, United States
Founded Date:
2016-04-01
Employee Number:
1-10
Last Funding Type:
Series C
Total Funding:
130000000.0
Estimated Revenue:
$50M to $100M
Industry:
Med Tech
Investors Number:
23.0
Technology:
['BioTech & HealthTech']
Investor Type:
Company
Last Funding Date:
2022-12-15
Number Of Exists:
Series A
Investment Stage:
N/A